DaehanPharmaceutical operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares DaehanPharmaceutical with three other
companies in this sector in South Korea:
Kolon Life Science Incorporation
sales of 132.68 billion Korean Won [US$117.16 million]
(179.32 billion Korean Won [US$158.34 million]
of which 93%
was Medicine), and
Ctc Bio, Incorporation.
(138.40 billion Korean Won [US$122.21 million]
of which 74%
was Animal Medication).
DaehanPharmaceutical reported sales of 158.72 billion Korean Won (US$140.15 million)
December of 2018.
increase of 9.9%
versus 2017, when the company's sales were 144.44 billion Korean Won.
Sales at DaehanPharmaceutical have increased during each of the previous five years
(and since 2013, sales have increased a total of 49%).